Commercialisation and scale up of a Vaginal Microbiome Screening service with a...
Commercialisation and scale up of a Vaginal Microbiome Screening service with a menstrual tampon collection device and a digital layer to provide diagnosis, disease risk evaluation and after
VMS is a home-based gynaecological test kit, using a menstrual tampon for sample collection. VMS will improve the accuracy and convenience with which STI, vaginal infections and HPV screening is undertaken.
Daye has patented the...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Duración del proyecto: 24 meses
Fecha Inicio: 2023-06-28
Fecha Fin: 2025-06-30
Líder del proyecto
TAMPONENI INOVATSII OOD
No se ha especificado una descripción o un objeto social para esta compañía.
Presupuesto del proyecto
4M€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
VMS is a home-based gynaecological test kit, using a menstrual tampon for sample collection. VMS will improve the accuracy and convenience with which STI, vaginal infections and HPV screening is undertaken.
Daye has patented the proprietary protocol for DNA extraction from a tampon for PCR analysis, testing for 16 different factors at a time. VMS can be used to detect vaginal dysbiosis, HPV and STIs, like chlamydia, gonorrhea and trichomoniasis. Vaginal microbiome screening with VMS will unlock invaluable insights into our customers’ vaginal health. There’s a direct correlation between vaginal microbiome health and the likelihood of contracting an STI, developing a gynecological cancer, experiencing fertility and pregnancy challenges, as well as susceptibility to recurrent vaginal and urethral infections.
Post screen, VMS will offer comprehensive aftercare, including prescriptions, doctor consultations, booking in-person visits, and vaginal microbiome enhancement plan with probiotics